Barinthus Biotherapeutics
  • Home
  • About Us
    • Overview
    • Our Team
    • A Name with Purpose
  • Approach
    • Overview
    • Tolerance Immunotherapies
  • Technology
    • Overview
    • Viral Vector Platforms
    • SNAP-TI
  • Pipeline
    • Overview
    • Infectious Diseases
    • Autoimmunity
    • Cancer
  • Partnerships
    • Overview
    • Infectious Diseases
    • Autoimmunity
  • Investors
    • Overview
    • News & Filings
    • Events & Presentations
    • Stock Information
    • Corporate Governance
    • Investor FAQs
    • Contact IR
  • Careers
    • Overview
    • Working Here
    • Diversity & Inclusion
    • Our Values
    • Recruitment Companies
  • Contact
    • Overview
    • Patient Enquiries
Select Page

SITEMAP

Looking for something in particular?

Pages

  • About Us
    • A Name with Purpose
    • Our Team
  • Careers
    • Recruitment Companies
  • Contact
    • Patient Enquiries
  • Data Protection Policy
  • Home
  • Partnerships
    • Autoimmunity
    • Cancer
    • Infectious Diseases
  • Pipeline
    • Autoimmunity
    • Cancer
    • Infectious Diseases
  • Privacy Notice
  • Privacy Policy
  • Technology
    • Synthetic Platforms
    • Viral Vector Platforms

Barinthus Biotherapeutics (UK) Ltd

3rd Floor
1 Ashley Road
Altrincham, Cheshire
WA14 2DT​
United Kingdom

T: +44 (0)1865 818808

Home
About
Sitemap
Privacy Policy
Privacy Notice
Careers
Contact

Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company focused on the development of antigen-specific immunotherapeutics that induce T cells to treat chronic viral infections, autoimmune diseases, and cancer.

© Barinthus Biotherapeutics 2023 All rights reserved.

  • Follow
  • Follow